These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38969298)

  • 1. Relaxin suppresses atrial fibrillation, reverses fibrosis and reduces inflammation in aged hearts.
    Romero G; Martin B; Gabris B; Salama G
    Biochem Pharmacol; 2024 Sep; 227():116407. PubMed ID: 38969298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin reverses maladaptive remodeling of the aged heart through Wnt-signaling.
    Martin B; Gabris B; Barakat AF; Henry BL; Giannini M; Reddy RP; Wang X; Romero G; Salama G
    Sci Rep; 2019 Dec; 9(1):18545. PubMed ID: 31811156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxin suppresses atrial fibrillation in aged rats by reversing fibrosis and upregulating Na+ channels.
    Henry BL; Gabris B; Li Q; Martin B; Giannini M; Parikh A; Patel D; Haney J; Schwartzman DS; Shroff SG; Salama G
    Heart Rhythm; 2016 Apr; 13(4):983-91. PubMed ID: 26711798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin abrogates genomic remodeling of the aged heart.
    Romero G; Salama G
    Vitam Horm; 2021; 115():419-448. PubMed ID: 33706957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxin reverses inflammatory and immune signals in aged hearts.
    Martin B; Gabris-Weber BA; Reddy R; Romero G; Chattopadhyay A; Salama G
    PLoS One; 2018; 13(1):e0190935. PubMed ID: 29346407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts.
    Parikh A; Patel D; McTiernan CF; Xiang W; Haney J; Yang L; Lin B; Kaplan AD; Bett GC; Rasmusson RL; Shroff SG; Schwartzman D; Salama G
    Circ Res; 2013 Jul; 113(3):313-21. PubMed ID: 23748429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo.
    Samuel CS; Unemori EN; Mookerjee I; Bathgate RA; Layfield SL; Mak J; Tregear GW; Du XJ
    Endocrinology; 2004 Sep; 145(9):4125-33. PubMed ID: 15155573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxin reduces susceptibility to post-infarct atrial fibrillation in mice due to anti-fibrotic and anti-inflammatory properties.
    Beiert T; Tiyerili V; Knappe V; Effelsberg V; Linhart M; Stöckigt F; Klein S; Schierwagen R; Trebicka J; Nickenig G; Schrickel JW; Andrié RP
    Biochem Biophys Res Commun; 2017 Aug; 490(3):643-649. PubMed ID: 28634079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease.
    Hiram R; Xiong F; Naud P; Xiao J; Sirois M; Tanguay JF; Tardif JC; Nattel S
    Cardiovasc Res; 2021 Jun; 117(7):1776-1789. PubMed ID: 32866246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdon deficiency causes cardiac remodeling through hyperactivation of WNT/β-catenin signaling.
    Jeong MH; Kim HJ; Pyun JH; Choi KS; Lee DI; Solhjoo S; O'Rourke B; Tomaselli GF; Jeong DS; Cho H; Kang JS
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):E1345-E1354. PubMed ID: 28154134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties.
    Beiert T; Knappe V; Tiyerili V; Stöckigt F; Effelsberg V; Linhart M; Steinmetz M; Klein S; Schierwagen R; Trebicka J; Roell W; Nickenig G; Schrickel JW; Andrié RP
    Int J Cardiol; 2018 Jan; 250():21-28. PubMed ID: 29169754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
    Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
    Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective actions of relaxin.
    Martin B; Romero G; Salama G
    Mol Cell Endocrinol; 2019 May; 487():45-53. PubMed ID: 30625345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers.
    Aragón-Herrera A; Couselo-Seijas M; Feijóo-Bandín S; Anido-Varela L; Moraña-Fernández S; Tarazón E; Roselló-Lletí E; Portolés M; Martínez-Sande JL; García-Seara J; Álvarez E; González-Juanatey JR; Rodríguez-Mañero M; Eiras S; Lago F
    Sci Rep; 2022 Dec; 12(1):22287. PubMed ID: 36566255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats.
    Lekgabe ED; Kiriazis H; Zhao C; Xu Q; Moore XL; Su Y; Bathgate RA; Du XJ; Samuel CS
    Hypertension; 2005 Aug; 46(2):412-8. PubMed ID: 15967869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal Transducer and Activator of Transcription 3/MicroRNA-21 Feedback Loop Contributes to Atrial Fibrillation by Promoting Atrial Fibrosis in a Rat Sterile Pericarditis Model.
    Huang Z; Chen XJ; Qian C; Dong Q; Ding D; Wu QF; Li J; Wang HF; Li WH; Xie Q; Cheng X; Zhao N; Du YM; Liao YH
    Circ Arrhythm Electrophysiol; 2016 Jul; 9(7):e003396. PubMed ID: 27406600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of relaxin on cardiac fibrosis, apoptosis, and tachyarrhythmia in rats with myocardial infarction.
    Wang D; Zhu H; Yang Q; Sun Y
    Biomed Pharmacother; 2016 Dec; 84():348-355. PubMed ID: 27668534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-fibrotic actions of relaxin are mediated through AT
    Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
    FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of miR-27b-3p Targeting Wnt3a Regulates the Signaling Pathway of Wnt/
    Lv X; Li J; Hu Y; Wang S; Yang C; Li C; Zhong G
    Oxid Med Cell Longev; 2019; 2019():5703764. PubMed ID: 31178968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation.
    Adam O; Lavall D; Theobald K; Hohl M; Grube M; Ameling S; Sussman MA; Rosenkranz S; Kroemer HK; Schäfers HJ; Böhm M; Laufs U
    J Am Coll Cardiol; 2010 Feb; 55(5):469-80. PubMed ID: 20117462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.